Cure Today3 天
FDA Accepts New Drug Application for Nubeqa Combo for Prostate Cancer Subset
The FDA will review an application to consider potential approval of Nubeqa plus androgen deprivation therapy for metastatic ...
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Bayer's efforts to expand Nubeqa's label in prostate cancer make progress with the FDA's acceptance of the company's sNDA.